0001012975-24-000083.txt : 20240214
0001012975-24-000083.hdr.sgml : 20240214
20240214143326
ACCESSION NUMBER: 0001012975-24-000083
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20231231
FILED AS OF DATE: 20240214
DATE AS OF CHANGE: 20240214
EFFECTIVENESS DATE: 20240214
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARCH Venture Management, LLC
CENTRAL INDEX KEY: 0001274403
ORGANIZATION NAME:
IRS NUMBER: 000000000
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-19358
FILM NUMBER: 24636171
BUSINESS ADDRESS:
STREET 1: C/O ARCH VENTURE PARTNERS
STREET 2: 8755 W. HIGGINS RD. #1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
BUSINESS PHONE: 7733806600
MAIL ADDRESS:
STREET 1: C/O ARCH VENTURE PARTNERS
STREET 2: 8755 W. HIGGINS RD. #1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
FORMER COMPANY:
FORMER CONFORMED NAME: ARCH VENTURE CORP
DATE OF NAME CHANGE: 20031224
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
false
false
false
0001274403
XXXXXXXX
12-31-2023
12-31-2023
ARCH Venture Management, LLC
C/O ARCH VENTURE PARTNERS
8755 W. HIGGINS RD. #1025
CHICAGO
IL
60631
13F HOLDINGS REPORT
028-19358
000158196
802-75688
N
Mark McDonnell
Managing Director, CFO and CAO
773-380-6600
/s/ Mark McDonnell
Chicago
IL
02-14-2024
0
7
163507430
false
INFORMATION TABLE
2
ARCH.xml
UNITY BIOTECHNOLOGY, INC.
COM
91381U200
1939297
1004817
SH
SOLE
0
0
1004817
DENALI THERAPEUTICS, INC.
COM
24823R105
8181604
381249
SH
SOLE
0
0
381249
GOSSAMER BIO, INC.
COM
38341P102
7351023
8055916
SH
SOLE
0
0
8055916
SINGULAR GENOMICS SYSTEMS, INC.
COM
82933R100
1747886
3798926
SH
SOLE
0
0
3798926
ERASCA, INC.
COM
29479A108
23548330
11055554
SH
SOLE
0
0
11055554
REVOLUTION MEDICINES, INC.
COM
76155X100
92736493
3233490
SH
SOLE
0
0
3233490
VERVE THERAPEUTICS, INC.
COM
92539P101
28002797
2008809
SH
SOLE
0
0
2008809